# Find your payout — Zantac (ranitidine) litigation

> Illustrative screening flow for Zantac (ranitidine) litigation. Not legal advice or a guarantee of eligibility.

**Canonical URL:** https://drugsmonitor.com/settlement-calculator/zantac-ranitidine-lawsuit
**Case overview:** https://drugsmonitor.com/case/zantac-ranitidine-lawsuit
**Litigation status:** Litigation concluded
**Last updated:** 2026-06-11

## What this tool does

The find-your-payout screener asks screening questions and may show an illustrative range with disclaimers before optional intake. Results are not predictions.

## Clinical context (summary)

Ranitidine was alleged to degrade into NDMA; federal MDL was largely dismissed in 2022 with limited residual activity.

---

*DrugsMonitor.com is not a law firm.*
